Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Astrazeneca plc ADR’s current trading price is -22.40% away from its 52-week high, while its distance from the 52-week low is 12.51%.
The market performance of Astrazeneca plc ADR has been somewhat unstable. Over the past year, the company’s stock achieved a high of $87.68 on 08/30/24, with the lowest value for the same timeframe being $60.47, recorded on 02/12/24. 52-week price history of AZN Stock A
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The metric has seen a significant gain of 1.69% since the start of this calendar year. Looking back over
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. This year’s metric has recorded a Price increase of 0.87%. However, over the past six months, we’ve
The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Astrazeneca plc ADR’s current trading price is -24.00% away from its 52-week high, while its distance from the 52-week low is 10.19%. The stock’s price
The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Astrazeneca plc ADR’s current trading price is -23.38% away from its 52-week high, while its distance from the 52-week low is 11.10%. The stock’s price
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. Year to date metric has recorded a gain of 0.34%.However, over the last six months,
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The index has shown a price gain of 1.40% this year. Over the last six months, there has been
After the German government recommended its administration to people aged 18 to 64 years of age only, AstraZeneca plc (AZN) defended its vaccine’s effectiveness against the new coronavirus in the elderly. A spokesman for the British-Swedish group AstraZeneca plc (AZN) explained that the newest analysis
Pharma giant AstraZeneca plc (NASDAQ: AZN) pulled out of talks in Brussels in response to delays in the coronavirus vaccine delivery, a development that represents another escalation between the company and the European Union, as reported by Bloomberg. European Union officials have been pressuring the company
All rights reserved © 2024, Powered By Smart TechOne
